Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features

Clin Drug Investig. 2019 Sep;39(9):915-916. doi: 10.1007/s40261-019-00839-9.

Author

Katherine A Lyseng-Williamson¹

Affiliation

¹ Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. DEcorrespondence@springer.com.

PMID: 31422551
DOI: 10.1007/s40261-019-00839-9

Abstract

The original version of this article unfortunately contained some mistakes. The corrected details are provided below.

Publication types

Published Erratum